OrthoPediatrics Corp.
DE ˙ DB ˙ US68752L1008
15,50 € ↑1,50 (10,71%)
2026-06-05
AKTIENPREIS
SecurityDE:2X7 / OrthoPediatrics Corp.
InstitutionFmr Llc
Latest Disclosed Ownership1,386 shares
Latest Disclosed Value $ 21,999
Fmr Llc reports 65.00% increase in ownership of 2X7 / OrthoPediatrics Corp.

On May 15, 2026 - Fmr Llc filed a 13F-HR form disclosing ownership of 1,386 shares of OrthoPediatrics Corp. (DE:2X7) valued at $18,018 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 840 shares of OrthoPediatrics Corp.. This represents a change in shares of 65.00% during the quarter. The current value of the position is $21,483 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ORTHOPEDIATRICS COM 68752L100 1,386 546 65.00 22 50.00 0.0000
2026-02-17 2025-12-31 13F ORTHOPEDIATRICS COM 68752L100 840 330 64.71 15 55.56 0.0000
2025-11-13 2025-09-30 13F ORTHOPEDIATRICS COM 68752L100 510 2 0.39 9 -10.00 0.0000
2025-08-14 2025-06-30 13F ORTHOPEDIATRICS COM 68752L100 508 -368 -42.01 11 -52.38 0.0000
2025-05-12 2025-03-31 13F ORTHOPEDIATRICS COM 68752L100 876 476 119.00 22 133.33 0.0000
2025-02-13 2024-12-31 13F ORTHOPEDIATRICS COM 68752L100 400 -935 -70.04 9 -75.00 0.0000
2024-11-13 2024-09-30 13F ORTHOPEDIATRICS COM 68752L100 1,335 157 13.33 36 9.09 0.0000
2024-08-13 2024-06-30 13F ORTHOPEDIATRICS COM 68752L100 1,178 -23 -1.92 34 -5.71 0.0000
2024-05-13 2024-03-31 13F ORTHOPEDIATRICS COM 68752L100 1,201 190 18.79 35 9.38 0.0000
2024-02-13 2023-12-31 13F ORTHOPEDIATRICS COM 68752L100 1,011 538 113.74 33 113.33 0.0000
2023-11-13 2023-09-30 13F ORTHOPEDIATRICS COM 68752L100 473 -506 -51.69 15 -64.29 0.0000
2023-08-11 2023-06-30 13F ORTHOPEDIATRICS COM 68752L100 979 105 12.01 43 10.53 0.0000
2023-08-11 2023-03-31 13F/A-1 ORTHOPEDIATRICS COM 68752L100 874 365 71.71 39 90.00 0.0000
2023-05-11 2023-03-31 13F ORTHOPEDIATRICS COM 68752L100 874 365 39 0.0000
2023-02-13 2022-12-31 13F ORTHOPEDIATRICS COM 68752L100 509 -142 -21.81 20 -33.33 0.0000
2022-11-10 2022-09-30 13F ORTHOPEDIATRICS COM 68752L100 651 40 6.55 30 15.38 0.0000
2022-08-12 2022-06-30 13F ORTHOPEDIATRICS COM 68752L100 611 29 4.98 26 -16.13 0.0000
2022-05-13 2022-03-31 13F ORTHOPEDIATRICS COM 68752L100 582 -524,492 -99.89 31 -99.90 0.0000
2022-02-14 2021-12-31 13F ORTHOPEDIATRICS COM 68752L100 525,074 23,179 4.62 31,431 -4.40 0.0023
2022-02-14 2021-09-30 13F/A-1 ORTHOPEDIATRICS COM 68752L100 501,895 119,043 31.09 32,879 35.93 0.0026
2021-11-15 2021-09-30 13F ORTHOPEDIATRICS COM 68752L100 501,895 119,043 32,879 0.0005
2021-08-13 2021-06-30 13F ORTHOPEDIATRICS COM 68752L100 382,852 291,512 319.15 24,189 443.21 0.0019
2021-05-14 2021-03-31 13F ORTHOPEDIATRICS COM 68752L100 91,340 -188,590 -67.37 4,453 -61.44 0.0004
2021-02-08 2020-12-31 13F ORTHOPEDIATRICS COM 68752L100 279,930 -191,491 -40.62 11,547 -46.66 0.0010
2020-11-13 2020-09-30 13F ORTHOPEDIATRICS COM 68752L100 471,421 -5,371 -1.13 21,648 3.76 0.0022
2020-08-24 2020-06-30 13F/A-1 ORTHOPEDIATRICS COM 68752L100 476,792 261,642 121.61 20,864 144.65 0.0023
2020-08-13 2020-06-30 13F ORTHOPEDIATRICS COM 68752L100 476,792 261,642 20,864 512.5674
2020-05-14 2020-03-31 13F ORTHOPEDIATRICS COM 68752L100 215,150 -206,290 -48.95 8,528 -56.94 0.0012
2020-02-07 2019-12-31 13F ORTHOPEDIATRICS COM 68752L100 421,440 72,340 20.72 19,803 60.88 0.0022
2019-11-13 2019-09-30 13F ORTHOPEDIATRICS COM 68752L100 349,100 78,341 28.93 12,309 16.57 0.0015
2019-08-13 2019-06-30 13F ORTHOPEDIATRICS COM 68752L100 270,759 -69,841 -20.51 10,559 -29.91 0.0012
2019-05-13 2019-03-31 13F ORTHOPEDIATRICS COM 68752L100 340,600 -74,000 -17.85 15,065 4.17 0.0018
2019-02-13 2018-12-31 13F ORTHOPEDIATRICS COM 68752L100 414,600 33,000 8.65 14,462 3.44 0.0020
2018-11-09 2018-09-30 13F ORTHOPEDIATRICS COM 68752L100 381,600 -7,400 -1.90 13,981 34.91 0.0016
2018-08-10 2018-06-30 13F ORTHOPEDIATRICS COM 68752L100 389,000 800 0.21 10,363 77.24 0.0012
2018-05-14 2018-03-31 13F ORTHOPEDIATRICS COM 68752L100 388,200 6,000 1.57 5,847 -20.28 0.0007
2018-02-12 2017-12-31 13F ORTHOPEDIATRICS COM 68752L100 382,200 382,200 7,334 0.0009
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.